Block Derivative Gain (Loss) Excluded from Effectiveness increased by 1.1% to -$53.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 208.5%, from -$17.24M to -$53.20M. Over 3 years (FY 2022 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows a downward trend with a 52.8% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$9.06M | -$9.06M | -$9.06M | -$9.06M | $3.16M | $3.94M | $21.42M | $18.70M | $18.75M | $1.87M | -$13.81M | -$16.11M | -$17.24M | -$23.69M | -$34.65M | -$53.78M | -$53.20M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +134.9% | +24.8% | +443.0% | -12.7% | +0.2% | -90.0% | -838.2% | -16.6% | -7.1% | -37.4% | -46.3% | -55.2% | +1.1% |
| YoY Change | — | — | — | — | +134.9% | +143.5% | +336.4% | +306.5% | +493.0% | -52.6% | -164.5% | -186.1% | -192.0% | <-999% | -150.9% | -233.9% | -208.5% |